This is a single center study to evaluate the pharmacokinetics of ARMS-I a formulation that
incorporates cetylpyridinium chloride (CPC), administered once as a single dose of three
sprays orally, followed by multiple dosing (3x daily oral sprays) over days 3-6 and then a
repeat pharmacokinetic study during the final oral dose administered as the first dose on day
7 to ascertain CPC accumulation.